• TRIM66 as an Epigenetic Repressor in Olfactory Receptor Choi

  2026-05-03

  This study identifies TRIM66 as a crucial epigenetic repressor that governs monogenic olfactory receptor expression in mice. The findings clarify how single olfactory sensory neurons restrict expression to one receptor, with implications for understanding sensory coding and epigenetic regulation.

• Adefovir (SKU C6629): Reliable Antiviral for HBV Research Wo

  2026-05-02

  This article addresses common laboratory challenges in hepatitis B virus (HBV) research, focusing on rigorous, scenario-driven solutions using Adefovir (SKU C6629). It covers experimental design, protocol optimization, and product reliability, providing quantitative evidence and actionable recommendations for biomedical scientists seeking reproducible, high-sensitivity results.

• 3D Organoid-CAF Co-Cultures Reveal Chemoresistance Mechanism

  2026-05-02

  Schuth et al. developed a patient-specific three-dimensional co-culture model of pancreatic cancer organoids and matched cancer-associated fibroblasts (CAFs), uncovering how stromal interactions fuel chemoresistance. Their work highlights the role of CAF-driven epithelial-to-mesenchymal transition and pro-inflammatory signaling in reducing chemotherapy efficacy, offering new insights for personalized oncology approaches.

• Protease Inhibitor Cocktail (EDTA-Free): Data-Driven Lab Sol

  2026-05-01

  This article explores real laboratory scenarios where the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO; SKU K4002) resolves common challenges in protein stability, data reproducibility, and workflow efficiency. Drawing on recent research and practical optimization, it demonstrates how this APExBIO reagent supports rigorous, reproducible protein science for cell viability and cytotoxicity assays.

• Dopamine Inhibits Osteoclastogenesis via cAMP/PKA/CREB Pathw

  2026-04-30

  Wang et al. reveal that dopamine suppresses osteoclast differentiation by inhibiting the cAMP/PKA/CREB signaling cascade in bone cells. This mechanistic insight advances our understanding of neural regulation in bone remodeling and suggests new directions for dissecting neurotransmitter-controlled bone metabolism.

• Morin: Applied Use-Cases for Mitochondrial and Enzyme Assays

  2026-04-30

  Morin, a high-purity natural flavonoid from APExBIO, empowers advanced workflows in mitochondrial metabolism, enzyme inhibition, and fluorescent ion detection. This article details actionable protocols, troubleshooting strategies, and unique advantages for researchers studying diabetes, oxidative stress, and podocyte injury.

• Vorinostat (SAHA, MK0683): Reliable HDAC Inhibition for Onco

  2026-04-29

  This article addresses common pain points in laboratory oncology research and provides scenario-driven guidance on overcoming experimental challenges using Vorinostat (SAHA, MK0683), SKU A4084. Drawing on data-backed insights, it details how this histone deacetylase inhibitor from APExBIO ensures reproducibility and sensitivity in apoptosis, proliferation, and epigenetic modulation assays.

• Super-Enhancer Hijacking of LINC01977 Drives LUAD via TGF-β/

  2026-04-29

  Zhang et al. reveal that the long noncoding RNA LINC01977, hijacked by a super-enhancer, amplifies early-stage lung adenocarcinoma (LUAD) malignancy by reinforcing canonical TGF-β/Smad3 signaling. Their multi-omics and functional analyses uncover a novel epigenetic feedback loop involving tumor-associated macrophages, with implications for targeted intervention in LUAD progression.

• Applied Use of AEBSF.HCl in Amyloid and Necroptosis Research

  2026-04-28

  AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) empowers precise modulation of serine protease activity in complex cell death and amyloid workflows. Explore how this APExBIO tool advances both mechanistic studies and troubleshooting in protease-driven pathways.

• Forsythoside E: Applied PKM2 Inhibition for Immunometabolic

  2026-04-28

  Forsythoside E empowers researchers to precisely modulate macrophage metabolism via targeted PKM2 inhibition, enabling robust immunometabolic assays and sepsis-induced liver injury models. Discover optimized workflows, troubleshooting strategies, and cross-referenced insights for maximizing assay reproducibility and translational relevance.

• Crossbreeding and Sex Shape Meat Quality: Multiomics in Xing

  2026-04-27

  This study rigorously assessed how crossbreeding and sex affect slaughter performance and meat quality in Xingguo gray geese, using integrated transcriptomic and metabolomic analyses. The research reveals molecular pathways underlying enhanced production traits, providing a data-driven foundation for breeding strategies and omics-driven meat science.

• SIRT1/2 Inhibitor IV (cambinol): Advanced Workflows & CNS In

  2026-04-27

  SIRT1/2 Inhibitor IV (cambinol) enables precise dissection of SIRT1/2-regulated pathways in cancer and CNS injury models, now with actionable workflows informed by new lactylation research. Explore protocol enhancements, troubleshooting strategies, and translational opportunities to elevate your cellular and in vivo studies.

• Oligo (dT) 25 Beads: Practical Guide for Eukaryotic mRNA Iso

  2026-04-26

  Oligo (dT) 25 Beads provide a robust solution for isolating polyadenylated mRNA from eukaryotic samples using magnetic bead-based technology. They are best suited for workflows requiring high-purity mRNA for downstream applications such as RT-PCR, first-strand cDNA synthesis, and next-generation sequencing. These beads are not intended for non-eukaryotic samples or applications requiring non-polyA RNA capture.

• Sulfo-Cy3 Azide: Optimizing Neurodevelopmental EdU Assays

  2026-04-25

  Explore how Sulfo-Cy3 azide empowers precise, photostable bioconjugation reagent workflows in neurodevelopmental research. This article provides a deep protocol analysis and practical assay guidance for Click Chemistry fluorescent labeling.

• PKM2 Inhibitor (Compound 3k): Optimizing Cancer Metabolism A

  2026-04-24

  PKM2 inhibitor (compound 3k) enables precise disruption of tumor glycolysis and immune cell metabolic reprogramming, uniquely supporting both oncology and immunometabolism workflows. Its selectivity and in vivo validation make it a benchmark tool for exploring PKM2-driven disease mechanisms and therapy.

16342 records 1/1090 page Next 12345 下5页 Last page